



years in 40% of pacients
Pancreatic islet xenotransplantation to reach normoglycaemia in T1D patients is the one with the greater potential. 
Clinical trials are being held but the ideal protocols to perform it are yet to be found.
New approaches are being studied to be able to reach a broad clinical application in the near future.
Regulations concerning xenotransplantation should be internationally harmonized. 
Public opinion about the potential risks associated with xenotransplantation should be explored, coupled with efforts to
educate society about the procedure.
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OBJECTIVES
Assess the potential of pancreatic islet xenotransplantation as a treatment of type 1 Diabetes Mellitus (T1D).
Summarize the genetic modifications that can be performed in pigs to overcome xenotransplantation main obstacles. 











Give anti-CD40mAb as immuno-
      suppressive 
Adaptative immune response
House the source-pigs in pathogen-
free conditions
Inactive PERVs from pig genome














If there's no immune
isolation, the islets are
infunded in the portal vein
or the omentum
IImmune isolated islets can
be implanted in the perito-
neum, the subcapsular kid-
ney space  or subcuta-
neously
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Figure 1: Neonatal islets xenotransplantation procedure
